Prostate Cancer - Results from #19560

Safety of antiandrogen therapy for treating prostate cancer - Abstract November 21, 2014

Can contemporary patients with biopsy Gleason score 3+4 be eligible for active surveillance? - Abstract November 21, 2014

PREFEREnce-based randomized evaluation of treatment modalities in low or early intermediate-risk prostate cancer - Abstract November 21, 2014

Incidental prostate cancer prevalence at radical cystoprostatectomy-importance of the histopathological work-up - Abstract November 21, 2014

Current treatment concepts for castration resistant prostate cancer - Abstract November 21, 2014

Burden of skeletal-related events in prostate cancer: Unmet need in pain improvement - Abstract November 21, 2014

Multiparametric magnetic resonance imaging predicts the presence of prostate cancer in patients with negative prostate biopsy - Abstract November 21, 2014

AUA Quality Improvement Summit 2014: Conference proceedings on infectious complications of transrectal prostate needle biopsy November 20, 2014

Diffuse large B-cell lymphoma of the prostate - Abstract November 20, 2014

Late toxicity and outcomes in high-risk prostate cancer patients treated with hypofractionated IMRT and long-term androgen suppression treatment - Abstract November 20, 2014

Risk of new-onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population - Abstract November 20, 2014

Highly-trained dogs' olfactory system detects prostate cancer in urine samples - Abstract November 20, 2014

Shear wave elastography for localization of prostate cancer lesions and assessment of elasticity thresholds: Implications for targeted biopsies and active surveillance protocols - Abstract November 20, 2014

Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: A meta-analysis of population-based observational studies - Abstract November 20, 2014

Robotic and minimal access surgery: Technology and surgical outcomes of radical prostatectomy for prostate cancer - Abstract November 20, 2014

Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide - Abstract November 19, 2014

Quality of life improvement for patients treated with degarelix versus leuprorelin in advanced prostate cancer - Abstract November 19, 2014

Optimal source distribution for focal boosts using high dose rate (HDR) brachytherapy alone in prostate cancer - Abstract November 19, 2014

Obesity increases the risk for high-grade prostate cancer: Results from the REDUCE study - Abstract November 19, 2014

Health-related quality of life in advanced prostate cancer and its treatments: Biochemical failure and metastatic disease populations - Abstract November 19, 2014

Page 979 of 1447